Kevin Waters - Mar 6, 2024 Form 4/A Insider Report for PROCEPT BioRobotics Corp (PRCT)

Role
EVP, CFO
Signature
/s/ Jonathan Stone, Attorney-in-Fact for Kevin Waters
Stock symbol
PRCT
Transactions as of
Mar 6, 2024
Transactions value $
$0
Form type
4/A
Date filed
4/19/2024, 07:06 PM
Date Of Original Report
Mar 7, 2024
Previous filing
Feb 13, 2024
Next filing
Mar 18, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRCT Common Stock Award $0 +13.3K +39.6% $0.00 46.8K Mar 6, 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRCT Stock Option (Right to Buy) Award $0 +11.6K $0.00 11.6K Mar 6, 2024 Common Stock 11.6K $47.17 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. 1/4th of the RSUs shall vest on the anniversary of the vesting commencement date of March 5, 2024, and annually over a three year period thereafter, subject to continued employment or service by the Reporting Person to the Issuer through the applicable vesting date.
F2 This Form 4 amendment corrects a clerical error in the number of shares of common stock granted in the form of RSUs to the reporting person on March 6, 2024. The incorrect total common stock share amount was also reported in one subsequent transaction on the original Form 4, and one subsequent Form 4 filed by the reporting person after the original Form 4 was filed.
F3 This Form 4 amendment corrects a clerical error in the number of shares underlying the stock option granted to the reporting person on March 6, 2024.
F4 1/48th of the shares subject to the Stock Option shall vest monthly from the vesting commencement date of March 5, 2024 over a four year period, subject continued employment or service by the Reporting Person to the Issuer through the applicable vesting date.